Skip to search formSkip to main contentSkip to account menu

Dorzolamide hydrochloride

The hydrochloride salt form of dorzolamide, an inhibitor of carbonic anhydrase, a zinc-containing enzyme that catalyzes the rapid conversion of… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
PURPOSE To study the effect of a single dose of topical dorzolamide hydrochloride 2%, a carbonic anhydrase inhibitor, on the… 
2003
2003
The behaviour of dorzolamide hydrochloride (DOR) was investigated at a glassy carbon electrode in different buffer systems using… 
Highly Cited
1998
Highly Cited
1998
PURPOSE To assess the effects of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor, on corneal endothelial… 
Highly Cited
1997
Highly Cited
1997
OBJECTIVES To measure the effectiveness of topical 2% dorzolamide hydrochloride (Trusopt, Merck & Co Inc, Whitehouse Station, NJ… 
1997
1997
OBJECTIVE To compare the efficacy and safety of topical 2.0% dorzolamide hydrochloride with oral acetazolamide in preventing… 
Review
1997
Review
1997
This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a…